New University of Texas MD Anderson Cancer Center Strategy Develops 2 Prototype Drugs Against Cancer, Retinal Diseases

EurekAlert! -- HOUSTON -- A comprehensive drug development strategy that starts with extensive screening of potential targeting agents and then narrows down to a small-molecule prototype has yielded two potential drugs that block cancer-promoting pathways in novel ways, a team led by scientists at The University of Texas M. D. Anderson Cancer Center reports in two papers published back-to-back online at the Proceedings of the National Academies of Science.